Quince Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Quince Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Quince Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -84.8 %, a 173% decline year-over-year.
  • Quince Therapeutics, Inc. annual Return On Equity for 2023 was -36.4 %, a 25.6% increase from 2022.
  • Quince Therapeutics, Inc. annual Return On Equity for 2022 was -48.9 %, a 25.4% increase from 2021.
  • Quince Therapeutics, Inc. annual Return On Equity for 2021 was -65.4 %, a 66.9% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -36.4 +12.5 +25.6% Jan 1, 2023 Dec 31, 2023
2022 -48.9 +16.6 +25.4% Jan 1, 2022 Dec 31, 2022
2021 -65.4 -26.2 -66.9% Jan 1, 2021 Dec 31, 2021
2020 -39.2 +4.16 +9.59% Jan 1, 2020 Dec 31, 2020
2019 -43.4 -87.8 -198% Jan 1, 2019 Dec 31, 2019
2018 44.5 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.